ask="3.33"
ask_size="2000"
average_daily_volume="68707"
bid="1.25"
bid_size="500"
book_value="1.19"
change="-0.10"
change_from_200_day_moving_average="-0.97"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-3.54"
change_From_52_week_low="0.42"
change_in_percent="-3.30%"
close="2.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="-0.83"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="5308000"
high="3.03"
high_52_weeks="6.47"
last_trade_date="3/1/2017"
last_trade_price="2.93"
last_trade_size="155"
last_trade_time="4:00pm"
low="2.90"
low_52_weeks="2.51"
market_capitalization="18.45M"
moving_average_200_day="3.90"
moving_average_50_day="3.00"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="3.03"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-24.78%"
percent_change_from_50_day_moving_average="-2.37%"
percent_change_from_52_week_high="-54.75%"
percent_change_from_52_week_low="+16.56%"
previous_close="3.03"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.54"
price_per_sales="21.07"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.82"
stock_exchange="NCM"
symbol="MBVX"
volume="17253"
weeks_range_52="2.51 - 6.47"
